Displaying items by tag: department of biochemistry and molecular genetics

This polygenic score predicts tamoxifen treatment resistance is better than conventional methods, with potential for personalized medicine application.
Bacterial viruses, known as phages, are the most abundant biological entities on the planet and are increasingly used as biomedicines to eradicate antibiotic-resistant pathogenic bacteria.
These nanowires, which can transport electrons to help a microbe make energy, were first described in a Geobacter bacteria; but now nanowires appear to be widespread in both bacteria and archaea prokaryotes.
UAB researchers have discovered a new way to treat melanoma by targeting CDC7 with EZH2 or BRPF1/2/3 inhibitors.
Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.
Tagged under
The histone methyltransferase DOT1L — the potential target — is overexpressed in ovarian cancer, and high levels of expression correlate with reduced progression-free and overall survival.
Meier-Gorlin syndrome is a rare genetic developmental disorder that causes dwarfism, small ears, a small brain, missing patella and other skeletal abnormalities.
Everyone was fast this spring: the businesses that contributed to the fund, the scientists and physicians who crafted research proposals, and the senior School of Medicine researchers who chose which proposals got money.
The research is led by an Oregon cancer research institute, in collaboration with two biotech companies and the National Institutes of Health.

The Gilbert Family Foundation’s Gene Therapy Initiative funds researchers at UAB exploring developmental and curative therapies for NF1.

Doctoral student Kwaku Osei came to UAB to learn from top researchers in the dry eye field. His work focuses on a tear film component that could provide a new way to treat a growing vision problem.
Page 1 of 3